FY Total Cost | Project Title | Principal Investigator | Organization | Year | NIH Institute | |||
$1,968,645 | PROSTATE CANCER IMAGING | CHOYKE, PETER L | NATIONAL CANCER INSTITUTE | 2009 | NCI | |||
$1,686,909 | MOLECULAR PROFILING OF CLINICAL SPECIMENS | EDELMAN, DANIEL | NATIONAL CANCER INSTITUTE | 2009 | NCI | |||
$1,476,952 | HUMAN RECQ HELICASES IN BIOLOGY AND ONCOLOGY | MONNAT, RAYMOND J | UNIVERSITY OF WASHINGTON | 2009 | NCI | |||
$1,309,745 | NANOTECHNOLOGY LINKING BIOMARKERS WITH CANCER BEHAVIOR |
NIE, SHUMING | EMORY UNIVERSITY | 2008 | NCI | |||
$787,458 | ANGIOGENESIS IMAGING | CHOYKE, PETER L | NATIONAL CANCER INSTITUTE | 2009 | NCI | |||
$657,451 | A PROTEOMICS PLATFORM FOR QUANTITATIVE, ULTRA-HIGH THROUGHPUT, AND ULTRA-SENSITIV |
SMITH, RICHARD D | BATTELLE PACIFIC NORTHWEST LABORATORIES | 2010 | NCI | |||
$581,526 | EPITOMIC BIOMARKERS OF PROSTATE CANCER | CHINNAIYAN, ARUL M | UNIVERSITY OF MICHIGAN AT ANN ARBOR | 2008 | NCI | |||
$524,925 | "MOLECULAR SIGNATURES OF LETHAL AND INDOLENT PROSTATE CANCER" |
RUBIN, MARK A. | WEILL MEDICAL COLLEGE OF CORNELL UNIV | 2010 | NCI | |||
$476,035 | DEVELOPMENT OF IMAGING BIOMARKERS FOR TREATMENT RESPONSE |
ROSS, BRIAN D. | UNIVERSITY OF MICHIGAN AT ANN ARBOR | 2009 | NCI | |||
$449,756 | EPITOMIC BIOMARKERS OF PROSTATE CANCER | CHINNAIYAN, ARUL M | UNIVERSITY OF MICHIGAN AT ANN ARBOR | 2009 | NCI | |||
$397,168 | A PROTEOMICS PLATFORM FOR QUANTITATIVE, ULTRA-HIGH THROUGHPUT, AND ULTRA-SENSITIV |
SMITH, RICHARD D | BATTELLE PACIFIC NORTHWEST LABORATORIES | 2009 | NCI | |||
$377,561 | NOVEL BIOMARKERS IN OVARIAN CANCER | BIRRER, MICHAEL | MASSACHUSETTS GENERAL HOSPITAL | 2010 | NCI | |||
$320,588 | PROTEOMIC BIOMARKERS OF ALK+ LYMPHOMA | LIM, MEGAN S | UNIVERSITY OF MICHIGAN AT ANN ARBOR | 2010 | NCI | |||
$319,550 | PROGNOSTIC MARKERS FOR OVARIAN CANCER | MOK, SAMUEL C | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | 2010 | NCI | |||
$311,250 | HDGF: A NOVEL BIOMARKER AND THERAPETIC TARGET OF LUNG CANCER |
MAO, LI | UNIVERSITY OF MARYLAND BALTIMORE | 2009 | NCI | |||
$305,000 | A TOOL FOR ANALYSIS OF GENE-SPECIFIC DNA METHYLATION IN CLINICAL SAMPLES |
LEVENSON, VICTOR V | NORTHWESTERN UNIVERSITY | 2009 | NCRR | |||
$283,708 | CAP METASTASIS BIOMARKERS: VALIDATION/GENOMICS/BIOLOGY |
PARIS, PAMELA L | UNIVERSITY OF CALIFORNIA SAN FRANCISCO | 2009 | NCI | |||
$259,674 | GLYCAN MARKERS FOR THE EARLY DETECTION OF BREAST CANCER |
HANCOCK, WILLIAM S | NORTHEASTERN UNIVERSITY | 2009 | NCI | |||
$258,053 | DISCOVERY OF BIOMARKERS FOR LUNG CANCER METASTASIS | PATZ, EDWARD F | DUKE UNIVERSITY | 2008 | NCI | |||
$248,413 | NOVEL HYPERPOLARIZED C-13 AND N-15 BIOMARKERS FOR METABOLIC MR IMAGING OF CANCER |
CHEKMENEV, EDUARD | VANDERBILT UNIVERSITY | 2009 | NCI | |||
$223,194 | INTEDRATED IMAGAING AND TISSUE BIOMARKERS IN GLIOBLASTOMA MULTIFORME POST THERAPY |
CHANG, SUSAN M | UNIVERSITY OF CALIFORNIA SAN FRANCISCO | 2009 | NCI | |||
$178,380 | BIOMARKER MODELS OF PROSTATE CANCER OUTCOME AFTER RADIOTHERAPY |
POLLACK, ALAN | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE | 2009 | NCI | |||
$174,701 | PPARGAMMA: BIOMARKER FOR BREAST CANCER IN OLDER WOMEN |
SEO, PEARL H | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE | 2009 | NIA | |||
$128,711 | ACUPUNCTURE FOR DYSPHAGIA AFTER CHEMORADIATION FOR HEAD AND NECK CANCER |
LU, WEIDONG | HARVARD UNIVERSITY (MEDICAL SCHOOL) | 2009 | NCCAM | |||
$127,656 | MOLECULAR PROFILES OF COLORECTAL ADENOMAS BY ARRAY CGH |
HOSTETTER, GALEN H | TRANSLATIONAL GENOMICS RESEARCH INST | 2009 | NCI |
There are only 25 meaningful projects in 2008, 2009 and 2010 with over $120,000! And that is considering hundreds of millions spent on minority research, billions spent on social and behavioral sciences... The NIH should definitely clean house sometime soon...
1 comment:
It was amazing to see Victor Levinson's epigenetic biomarker project on the list. We saw many good publications stemming from this research.
Post a Comment